You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 37 Issue 1

January 2013

Volume 37, Issue 1

Pages 1–168

  1. Editors' declarations of interest

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
  2. REVIEW ARTICLES

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
      Review article: a comparison of glucagon-like peptides 1 and 2 (pages 18–36)

      P. Janssen, A. Rotondo, F. Mulé and J. Tack

      Article first published online: 5 NOV 2012 | DOI: 10.1111/apt.12092

    3. You have free access to this content
  3. RANDOMISED CLINICAL TRIALS

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
      Randomised clinical trials: linaclotide phase 3 studies in IBS-C – a prespecified further analysis based on European Medicines Agency-specified endpoints (pages 49–61)

      E. M. M. Quigley, J. Tack, W. D. Chey, S. S. Rao, J. Fortea, M. Falques, C. Diaz, S. J. Shiff, M. G. Currie and J. M. Johnston

      Article first published online: 1 NOV 2012 | DOI: 10.1111/apt.12123

    2. You have free access to this content
      Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma (pages 62–73)

      H.-S. Shiah, C.-Y. Chen, C.-Y. Dai, C.-F. Hsiao, Y.-J. Lin, W.-C. Su, J.-Y. Chang, J. Whang-Peng, P.-W. Lin, J.-D. Huang and L.-T. Chen

      Article first published online: 8 NOV 2012 | DOI: 10.1111/apt.12132

  4. HEPATITIS C

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
      Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism (pages 74–80)

      J. A. del Campo, J. Ampuero, L. Rojas, M. Conde, Á. Rojas, M. Maraver, R. Millán, M. García-Valdecasas, J. R. García-Lozano, M. F. González-Escribano and M. Romero-Gómez

      Article first published online: 5 NOV 2012 | DOI: 10.1111/apt.12113

    2. You have free access to this content
      Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C (pages 81–90)

      C.-C. Hu, C.-L. Lin, Y.-L. Kuo, C.-H. Chien, S.-W. Chen, C.-L. Yen, C.-Y. Lin and R.-N. Chien

      Article first published online: 5 NOV 2012 | DOI: 10.1111/apt.12112

    3. You have free access to this content
      The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma (pages 91–97)

      R. Cabrera, A. R. Limaye, P. Horne, R. Mills, C. Soldevila-Pico, V. Clark, G. Morelli, R. Firpi and D. R. Nelson

      Article first published online: 24 OCT 2012 | DOI: 10.1111/apt.12098

  5. BILIARY DYSKINESIA

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
  6. EOSINOPHILIC OESOPHAGITIS

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
      The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood (pages 114–121)

      P. Menard-Katcher, K. L. Marks, C. A. Liacouras, J. M. Spergel, Y.-X. Yang and G. W. Falk

      Article first published online: 5 NOV 2012 | DOI: 10.1111/apt.12119

  7. CLOSTRIDIUM DIFFICILE

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
      Rifaximin in the treatment of recurrent Clostridium difficile infection (pages 122–128)

      E. Mattila, P. Arkkila, P. S. Mattila, E. Tarkka, P. Tissari and V.-J. Anttila

      Article first published online: 24 OCT 2012 | DOI: 10.1111/apt.12111

  8. ULCERATIVE COLITIS

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
      Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis – experience in 130 patients (pages 129–136)

      K. J. Schmidt, K. R. Herrlinger, J. Emmrich, D. Barthel, H. Koc, H. Lehnert, E. F. Stange, K. Fellermann and J. Büning

      Article first published online: 5 NOV 2012 | DOI: 10.1111/apt.12118

  9. CHRONIC CONSTIPATION

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
  10. COLORECTAL CANCER

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
      Use of systemic glucocorticoids and the risk of colorectal cancer (pages 146–152)

      E. B. Ostenfeld, R. Erichsen, O. Thorlacius-Ussing, A. H. Riis and H. T. Sørensen

      Article first published online: 1 NOV 2012 | DOI: 10.1111/apt.12115

  11. INVITED COMMENTARIES

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Commentary: monitoring for myelosuppression in IBD – authors’ reply (page 155)

      J. K. Hou, J. R. Kramer, P. Richardson, S. Sansgiry and H. B. El-Serag

      Article first published online: 4 DEC 2012 | DOI: 10.1111/apt.12117

    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
    8. You have free access to this content
  12. LETTERS TO THE EDITORS

    1. Top of page
    2. Editors' declarations of interest
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C
    6. BILIARY DYSKINESIA
    7. EOSINOPHILIC OESOPHAGITIS
    8. CLOSTRIDIUM DIFFICILE
    9. ULCERATIVE COLITIS
    10. CHRONIC CONSTIPATION
    11. COLORECTAL CANCER
    12. INVITED COMMENTARIES
    13. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
    8. You have free access to this content
    9. You have free access to this content
      Letter: dyspepsia, anxiety and depression – authors' reply (pages 167–168)

      A. D. P. Mak, J. C. Y. Wu, Y. Chan, F. K. L. Chan, J. J. Y. Sung and S. Lee

      Article first published online: 4 DEC 2012 | DOI: 10.1111/apt.12151

SEARCH

SEARCH BY CITATION